₹ 384.88 Cr
3.01%
Nifty Healthcare TRI
INF966L01CH1
5000.0
1000.0
1000
Sandeep Tandon, Ankit Pande, Varun Pattani, Ayusha Kumbhat, Yug Tibrewal, Sameer Kate, Sanjeev Sharma
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - IDCW Option - Regular Plan | 9.37 | 18.39 | - |
| NIFTY Healthcare TRI | 11.45 | 20.62 | 14.25 |
Equity
Debt
Others
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| TREPS 01-Jun-2026 DEPO 10 | 24.761066 |
| HFCL LIMITED EQ NEW F.V.RE.1/- | 9.551234 |
| Torrent Pharmaceuticals Ltd 30/06/2026 | 9.446842 |
| Divis Laboratories Limited 30/06/2026 | 9.328119 |
| Zydus Wellness Ltd | 8.735329 |
| ASTER DM HEALTHCARE LIMITED EQ | 8.733815 |
| ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/- | 8.657031 |
| SMS PHARMACEUTICALS LIMITED EQ NEW FV Re.1/- | 7.659903 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 6.979033 |
| PFIZER LIMITED EQ | 5.919938 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 47.45 |
| Telecommunication | 9.55 |
| Fast Moving Consumer Goods | 8.74 |
| Financial Services | 3.73 |